Matsumoto T et al. |
Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. |
1997 |
Lancet |
pmid:9228971
|
DÃaz F et al. |
[Cat-scratch disease. A report of 4 cases and a review of the literature]. |
1997 |
Rev Clin Esp |
pmid:9102668
|
Horgen L et al. |
Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium. |
1997 |
Res. Microbiol. |
pmid:9765852
|
Axon AT et al. |
Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9042977
|
Gotoh A et al. |
Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori. |
1997 |
Microbiol. Immunol. |
pmid:9444328
|
Labenz J et al. |
One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9042978
|
Labenz J et al. |
Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9042979
|
Goh KL et al. |
Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection? |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663838
|
Buckley MJ et al. |
Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance. |
1997 |
Dig. Dis. Sci. |
pmid:9365144
|
Misiewicz JJ et al. |
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. |
1997 |
Gut |
pmid:9462204
|
Loo VG et al. |
In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole. |
1997 |
J. Antimicrob. Chemother. |
pmid:9462442
|
Hotz J |
[Reflux disease of the gastrointestinal tract. Acute therapy and long-term care in daily practice. 2. Therapeutic procedure--diagnosis--therapy-diagram]. |
1997 |
Fortschr. Med. |
pmid:9480263
|
Klein JO |
History of macrolide use in pediatrics. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109154
|
Kato A |
[Effect of erythromycin and clarithromycin on ion transport across dissected canine tracheal epithelium]. |
1997 |
Nippon Jibiinkoka Gakkai Kaiho |
pmid:9103848
|
Meyer JM et al. |
In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9210696
|
Chimura T |
[Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection]. |
1997 |
Jpn J Antibiot |
pmid:9212369
|
Phull PS et al. |
Lansoprazole plus clarithromycin: evaluation of a new dual therapy for Helicobacter pylori eradication. |
1996 Oct-Nov |
Br J Clin Pract |
pmid:9015906
|
Peeling RW and Brunham RC |
Chlamydiae as pathogens: new species and new issues. |
1996 Oct-Dec |
Emerging Infect. Dis. |
pmid:8969247
|
Prescott LM |
Clarithromycin for MAC prevention offers additional benefits. |
1996 May-Jun |
Posit Aware |
pmid:11363431
|
Mertl SL |
The role of clarithromycin in the prophylaxis of disseminated Mycobacterium avium-intracellulare infection in patients with AIDS. |
1996 May-Jun |
Pharmacotherapy |
pmid:8726597
|
Ono T et al. |
In vitro and in vivo antibacterial activities of clarithromycin. |
1996 May-Jun |
Chemotherapy |
pmid:8983882
|
Nightingale SL |
From the Food and Drug Administration. |
1996 May 22-29 |
JAMA |
pmid:8622234
|
Sketris IS et al. |
Possible role of the intestinal P-450 enzyme system in a cyclosporine-clarithromycin interaction. |
1996 Mar-Apr |
Pharmacotherapy |
pmid:8820476
|
Akamatsu H et al. |
Enhanced effect of clarithromycin on neutrophil function in vitro. |
1996 Mar-Apr |
J. Int. Med. Res. |
pmid:8737228
|
Papp J et al. |
Efficacy of nizatidine, clarithromycin and bismuth subcitrate therapy for Helicobacter pylori eradication in duodenal ulcer patients--a preliminary report. |
1996 Jul-Aug |
Br J Clin Pract |
pmid:8794601
|
Tursi A et al. |
One-week low-dose triple therapy vs. two-week medium-dose double therapy for H.pylori infection. |
1996 Jul-Aug |
Hepatogastroenterology |
pmid:8884304
|
Amsden GW |
Erythromycin, clarithromycin, and azithromycin: are the differences real? |
1996 Jan-Feb |
Clin Ther |
pmid:8851453
|
Sander P et al. |
Ribosomal drug resistance in mycobacteria. |
1996 Jan-Feb |
Res. Microbiol. |
pmid:8761724
|
Shafran SD et al. |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. |
1996 |
N. Engl. J. Med. |
pmid:8676931
|
Shimoyama T et al. |
Validity of various diagnostic tests to evaluate cure of Helicobacter pylori infection. |
1996 |
J. Gastroenterol. |
pmid:8680535
|
MacConnachie AM |
Clarithromycin (klaricid, Abbott). |
1996 |
Intensive Crit Care Nurs |
pmid:8696027
|
Meier A et al. |
Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. |
1996 |
J. Infect. Dis. |
pmid:8699066
|
O'Hara K and Yamamoto K |
Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849224
|
Flurer CL |
Analysis of macrolide antibiotics by capillary electrophoresis. |
1996 |
Electrophoresis |
pmid:8900943
|
Vermot D et al. |
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8851620
|
van der Hulst RW et al. |
Therapeutic options after failed Helicobacter pylori eradication therapy. |
1996 |
Am. J. Gastroenterol. |
pmid:8931413
|
Alder JD et al. |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies. |
1996 |
Am. J. Gastroenterol. |
pmid:8931416
|
Koeck JL et al. |
Disseminated Mycobacterium simiae infection in a patient with AIDS: clinical features and treatment. |
1996 |
Clin. Infect. Dis. |
pmid:8909856
|
Hunt RH |
Eradication of Helicobacter pylori infection. |
1996 |
Am. J. Med. |
pmid:8644782
|
Dhaenens L et al. |
In-vitro activities of clarithromycin and other antimicrobial agents against Helicobacter pylori isolated from children. |
1996 |
J. Antimicrob. Chemother. |
pmid:8877551
|
Tursi A et al. |
Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis. |
1996 |
J. Clin. Gastroenterol. |
pmid:8877648
|
Thor P et al. |
Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with non-ulcer dyspesia. |
1996 |
J. Physiol. Pharmacol. |
pmid:8877902
|
Ji B et al. |
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878595
|
Ji B et al. |
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834886
|
Yamamoto T et al. |
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834892
|
Ji B et al. |
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice? |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834894
|
Dattwyler RJ et al. |
Clarithromycin in treatment of early Lyme disease: a pilot study. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834900
|
Jaup BK |
Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin, and clarithromycin. |
1996 |
Helicobacter |
pmid:9398878
|
Moayyedi P et al. |
Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori. |
1996 |
Helicobacter |
pmid:9398880
|
Mégraud F and Malfertheiner P |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995. |
1996 |
Helicobacter |
pmid:9398889
|